You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Vandetanib

Showing 51 - 75 of 118
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Stanford (Vandetanib, Anastrozole)

Terminated
Has Results
  • Breast Cancer
  • Stanford, California
    Stanford University School of Medicine
Dec 13, 2016

Tumors, Lung Tumors, Colon Tumors Trial in Idaho Falls (Provider determined)

Terminated
  • Neoplasms
  • +24 more
  • Provider determined
  • Idaho Falls, Idaho
    Teton Cancer Institute
Mar 29, 2019

Small Cell Lung Cancer Trial in United States (Cisplatin, Etoposide, Placebo)

Completed
Has Results
  • Small Cell Lung Cancer
  • Newark, Delaware
  • +18 more
Feb 7, 2020

Unresectable Locally Advanced or Metastatic, Medullary Thyroid Carcinoma Trial in Japan (Vandetanib 300mg)

Completed
Has Results
  • Unresectable Locally Advanced or Metastatic, Medullary Thyroid Carcinoma
  • Vandetanib 300mg
  • Fukuoka-shi, Japan
  • +3 more
Oct 11, 2016

Thyroid Carcinoma Trial in France (Continuous pazopanib (Arm A), Intermittent pazopanib (Arm B))

Completed
  • Thyroid Carcinoma
  • Continuous pazopanib (Arm A)
  • Intermittent pazopanib (Arm B)
  • Angers, France
  • +12 more
Aug 14, 2019

Breast Cancer Trial in Italy (ZD6474 (Vandetanib at the dose of 100 mg), Placebo to match ZD6474 (Vandetanib at the dose of 100

Terminated
Has Results
  • Breast Cancer
  • ZD6474 (Vandetanib at the dose of 100 mg)
  • +4 more
  • Avellino, Italy
  • +10 more
Oct 11, 2016

Biliary Tract Cancer, Gallbladder Cancer, Cancer Of The Extrahepatic Bile Duct Trial in Italy (ZD6474, Vandetanib, Gemcitabine,

Completed
Has Results
  • Biliary Tract Cancer
  • +3 more
  • ZD6474, Vandetanib
  • +2 more
  • Brescia, BS, Italy
  • +14 more
Aug 29, 2016

Carcinoma, Hepatocellular Trial in Tainan, Taipei, Taoyuan (Vandetanib, Best Supportive Care)

Completed
Has Results
  • Carcinoma, Hepatocellular
  • Vandetanib
  • Best Supportive Care
  • Tainan, Taiwan
  • +2 more
Aug 29, 2016

Ovarian Cancer Trial in Germany (Vandetanib)

Terminated
Has Results
  • Ovarian Cancer
  • Vandetanib
  • Ulm, Baden-Württemberg, Germany
  • +4 more
Aug 29, 2016

Mesothelioma Trial in Germany, Switzerland (Vinorelbine, Vandetanib)

Terminated
Has Results
  • Mesothelioma
  • Essen, Germany
  • +5 more
Aug 29, 2016

Prostate Cancer Trial in Canada (vandetanib, Placebo)

Terminated
Has Results
  • Prostate Cancer
  • vandetanib
  • Placebo
  • Calgary, Alberta, Canada
  • +10 more
Oct 27, 2016

Vandetanib Risk Minimisation Effectiveness

Completed
  • Medullary Thyroid Cancer
    • Montreal, Quebec, Canada
      Research Site
    Aug 30, 2016

    Healthy Volunteers Trial in Overland Park (Digoxin, Vandetanib)

    Completed
    • Healthy Volunteers
    • Overland Park, Kansas
      Research Site
    Aug 26, 2016

    Healthy Trial in Overland Park (Metformin 1000 mg, Vandetanib 800 mg)

    Completed
    • Healthy
    • Metformin 1000 mg
    • Vandetanib 800 mg
    • Overland Park, Kansas
      Research Site
    Aug 26, 2016

    Healthy Volunteers Trial in Overland Park (Midazolam, vandetanib)

    Completed
    • Healthy Volunteers
    • Overland Park, Kansas
      Research Site
    Aug 26, 2016

    Non Small Cell Lung Cancer Trial in Italy (ZD6474, Vandetanib, Placebo to Match ZD6474, Vandetanib, Gemcitabine)

    Completed
    Has Results
    • Non Small Cell Lung Cancer
    • ZD6474, Vandetanib
    • +2 more
    • Meldola, (fc), Italy
    • +14 more
    Aug 30, 2016

    Carcinoma, Non-Small Cell Lung, Lung Cancer Trial (ZD6474 (vandetanib) 100mg, pemetrexed, ZD6474 (vandetanib) 300mg)

    Completed
    • Carcinoma
    • +2 more
    • ZD6474 (vandetanib) 100mg
    • +2 more
    • (no location specified)
    Aug 24, 2016

    NSCLC (NSCLC) Trial in Amsterdam, Groningen, Maastricht (ZD6474 (Vandetanib), Whole Brain Radiotherapy (WBRT), ZD6474)

    Terminated
    • Non-small Cell Lung Cancer (NSCLC)
    • ZD6474 (Vandetanib)
    • +2 more
    • Amsterdam, Netherlands
    • +2 more
    Aug 26, 2016

    NSCLC Trial in Korea, Republic of (Vandetanib, Placebo)

    Completed
    Has Results
    • NSCLC
    • Vandetanib
    • Placebo
    • CheongJu, Republic of Korea, Korea, Republic of
    • +4 more
    Aug 29, 2016

    Non Small Cell Lung Cancer Trial in Worldwide (Vandetanib, Erlotinib)

    Completed
    Has Results
    • Non Small Cell Lung Cancer
    • Berkeley, California
    • +152 more
    Jan 24, 2018

    Metastatic, Colorectal, Adenocarcinoma Trial in Gent, Belfast, Manchester (ZD6474 (vandetanib) 100mg, Irinotecan,

    Completed
    • Metastatic
    • +2 more
    • ZD6474 (vandetanib) 100mg
    • +4 more
    • Gent, Belgium
    • +2 more
    Aug 24, 2016

    Advanced Solid, Malignant Tumors Trial in Guangzhou (Vandetanib, Vandetanib 300 mg)

    Completed
    • Advanced Solid, Malignant Tumors
    • Vandetanib
    • Vandetanib 300 mg
    • Guangzhou, China
      Research Site
    Aug 29, 2016

    Thyroid Cancer Trial in Worldwide (ZD6474 (vandetanib))

    Completed
    Has Results
    • Thyroid Cancer
    • ZD6474 (vandetanib)
    • Little Rock, Arkansas
    • +8 more
    Dec 7, 2016

    Non Small Cell Lung Carcinoma Trial in Japan (ZD6474 (vandetanib) 100mg, ZD6474 (vandetanib) 200mg, ZD6474 (vandetanib) 300mg)

    Completed
    • Non Small Cell Lung Carcinoma
    • ZD6474 (vandetanib) 100mg
    • +2 more
    • Matsuyama, Ehime, Japan
    • +6 more
    Aug 24, 2016

    Prostate Cancer Trial in France (ZD6474 (Vandetanib), Bicalutamide, Placebo)

    Completed
    Has Results
    • Prostate Cancer
    • ZD6474 (Vandetanib)
    • +2 more
    • Bordeaux Cedex, France
    • +4 more
    Oct 11, 2016